Pharmaxis Ltd. (PXS.AX)


ASX - ASX Delayed Price. Currency in AUD
0.28+0.01 (+3.77%)
At close: 2:10 AM EDT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open0.31
Prev Close0.26
Bid0.00 x
Ask0.00 x
Day's Range0.28 - 0.31
52wk Range0.21 - 0.41
1y Target EstN/A
Market Cap87.27M
P/E Ratio (ttm)-5.29
BetaN/A
Volume1,884,778
Avg Vol (3m)314,791
Dividend & YieldN/A (N/A)
Earnings DateN/A
  • Pharmaxis Ltd. :PXS-AU: Earnings Analysis: Q2, 2016 By the Numbers
    Capital Cube6 months ago

    Pharmaxis Ltd. :PXS-AU: Earnings Analysis: Q2, 2016 By the Numbers

    Click here to see latest analysisPharmaxis Ltd. reports financial results for the quarter ended December 31, 2015.HighlightsGross margins narrowed from 4.57% to -126.60% compared to the same period last year, operating (EBITDA) margins now -465.67% from -465.84%.Earnings growth from operating margin improvements as well as one-time items.The table below shows the preliminary results and recent […] (Read more...) The post Pharmaxis Ltd. :PXS-AU: Earnings Analysis: Q2, 2016 By the Numbers appeared first on CapitalCube.

  • Motley Fool2 years ago

    The big reason why Pharmaxis Ltd shares slumped today

    Biotech could be running out of options

  • Motley Fool2 years ago

    Here's why Bionomics Ltd shares soared today

    Is this a new beginning for Bionomics?